The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 09, 2024

Filed:

Jun. 20, 2017
Applicant:

Merz Pharma Gmbh & Co. Kgaa, Frankfurt am Main, DE;

Inventors:

Fred Hofmann, Potsdam, DE;

Marcel Jurk, Berlin, DE;

Manuela López De La Paz, Liederbach am Taunus, DE;

Daniel Scheps, Potsdam, DE;

Jürgen Frevert, Berlin, DE;

Assignee:

MERZ PHARMA GMBH & CO. KGAA, Frankfurt am Main, DE;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/33 (2006.01); A61K 8/66 (2006.01); A61K 38/16 (2006.01); C12N 9/52 (2006.01); C12N 15/52 (2006.01); C12N 15/70 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
C12N 9/52 (2013.01); A61K 8/66 (2013.01); C12Y 304/24069 (2013.01); A61K 38/00 (2013.01); C07K 2319/31 (2013.01);
Abstract

This invention relates to novel recombinant clostridial neurotoxins exhibiting an increased duration of effect without a delayed onset of effect and to methods for the manufacture of such recombinant clostridial neurotoxins. These novel recombinant clostridial neurotoxins comprise a domain consisting of proline, alanine, serine, threonine, glycine and glutamate residues, and the methods comprise the steps of inserting a nucleic acid sequence coding for said domain into a nucleic acid sequence coding for a parental clostridial neurotoxin and expression of the recombinant nucleic acid sequence comprising said domain-coding sequence in a host cell. The invention further relates to novel recombinant single-chain precursor clostridial neurotoxins used in such methods, nucleic acid sequences encoding such recombinant single-chain precursor clostridial neurotoxins, and pharmaceutical compositions comprising the recombinant clostridial neurotoxin with an increased duration of effect without a delayed onset of effect.


Find Patent Forward Citations

Loading…